Editorial: Neuroimmunology in Africa

Résumé

In the 1970s and 1980s, neuroscience research appeared sporadically in North and South Africa in the form of isolated publications from European-trained academics who joined universities in their home countries. Research was mostly clinical, developed on understanding diseases and developing treatments for neurological disorders such as epilepsy, motor disorders, but also infectious diseases: leprosy, tetanus, meningitis, encephalitis, which will later all come under the field of immunology and neuroimmunology. In some countries, research began to be structured around national associations or societies such as the Moroccan Association of Neuroscience (AMN; 1987), followed by the Southern African Society of Neurosciences (SANS; 1988), the Neuroscience Society of Nigeria (NSN; 1990) and Kenya Society for Neurosciences (KSN;1992-1993. The Society of African Neuroscientists (SONA) was founded at the end of a scientific conference organized in 1993 in Kenya, federating the existing African Neuroscience Associations and Societies which were 4 at the time, and any individual researcher agreeing to be a member. The International Brain Research Organization (IBRO) has regularly supported all the activities of the SONA, which organizes a biannual congress. Other international organizations have also been involved in promoting SONA under various policies, the International Society for Neurochemistry (ISN) being a special example.The need to take ownership of neuroscience training was felt and IBRO understood that it was necessary to sponsor neuroscience education in Africa for sustainable development. The first African school in neuroscience was organized in 2000 in South Africa. For more than 20 years now, IBRO has been generously supporting neuroscience schools and training workshops in more than 14 African countries. In addition to schools, two regular workshops were organized in conjunction with SONA conferences: Writing paper workshop and Teaching Tools workshop. ISN has also contributed significantly to the funding of these activities. In 2015, IBRO created two regularly funded advanced neuroscience training centers (IBRO African Centers for Advanced Training in Neuroscience: ACATN): the first in Cape Town in 2015 and the second in Rabat in 2016. These centers were to organize two to three advanced training courses every year on value-added themes for Africa, with at least one regular school per center. The Cape-Town center specialized in Computational neuroscience and the Rabat center on Basal Ganglia and Movement Disorders. In addition, the Rabat center hosted two neuroimmunology schools, in 2017 and 2019, supported also by the International Society of Neuroimmunology (ISNI) through the African School of Neuroimmunology. From these came the idea of this collection "Neuroimmunology in Africa". This collection follows the path of previous collections focusing on neuroscience in Africa. A first collection appeared in Frontiers in Neuroanatomy on "Neuroscience in Africa" in 2019 [4], followed by another collection published as a Special edition of IBRO neuroscience reports titled "Neuroscience in Africa" in 2023 [5].The momentum that neuroscience in Africa has gained, boosted by these investments in education, can be appreciated in Figure 1, showing that the number of publications in this area co-authored by researchers with African institutional affiliations has been almost doubling every five years, starting from 1995. This impressive growth was especially driven by nations like Algeria, Cameroon, Egypt, Ethiopia, Ghana, Kenya, Morocco, Nigeria, South Africa, although a steady increase, with a similar slope, can be appreciated also in nations with a more limited output in terms of neuroscience publications. The total disease burden in Africa is still dominated by communicable diseases [6]. Ngarka et al. sum up the interplay between neuroinfections, the immune system and neurological disorders with a special emphasis on neurological diseases common in Africa as a sequelae of neuroinfections. Neurological disorders associated with HIV infection such as HIVassociated neurocognitive disorders, motor disorders, chronic headaches, and peripheral neuropathy are high in the sub-Saharan region because of high prevalence of HIV. The immune system deregulation in addition to the virus and antiretroviral drugs contribute to these neurological disorders. Infections such as toxoplasmosis, neurocysticercosis, onchocerciasis, malaria, bacterial meningitis, tuberculosis, and the immune reactions they elicit contribute to the high prevalence of epilepsy on the continent. Other neurological disorders attributable to neuroinfections and the neuroimmune response they trigger include sleep disorders, secondary headaches, dementia, motor neuron diseases. Ihunwo et al. explain how some viruses can get to the brain and affect neurogenesis. Zika virus can infect fetal brain and affect neural stem cells, neurogenesis, synaptogenesis, and cause cell death, with severe consequences such as microcephaly and decreased brain tissue. Severe acute respiratory syndrome coronavirus 2 can infect the olfactory bulb and travel to the CNS by retrograde axonal transport along olfactory sensory neurons, target neurons, astrocytes, and microglia and result in neurological symptoms observed in coronavirus disease 2019 (COVID-19) patients. Ndondo et al. review postinfectious autoimmunity in the CNS and peripheral nervous systems, pointing out the peculiarities in Africa. They cover the various conditions that occur after viral infections such as acute necrotizing encephalopathy, measles-associated encephalopathies, HIV neuroimmune disorders, and difficulties associated with classical post-infectious autoimmune disorders such as the Guillain-Barré syndrome in the context of HIV and other infections. NMDA-R encephalitis and myasthenia gravis, as the classic antibody-mediated disease, are also covered. Teunissen et al. summarize research in the use of biomarkers in tuberculous meningitis and pediatric HIV. They explain the possible diagnostic and prognostic values of some inflammatory molecules, such as cytokines and chemokines, and brain injury molecules, such as S100, neuron specific enolase and glial fibrillary acidic protein, when detected in the CSF.The only original research article in the theme by Bertran-Cobo et al., conducted in South Africa, found that myo-inositol, a marker for glial reactivity and inflammation, was elevated in children who are HIV-exposed and uninfected, which points to ongoing neuroinflammatory processes that may contribute to developmental risk in these children.The prevalence of non-communicable diseases is increasing on the African continent [6]. Ballerini et al. review non-communicable neurological disorders and neuroinflammation, focusing on traumatic brain injury (TBI), stroke, and neurodegenerative diseases such as dementias because they represent a major cause of morbidity and mortality in Africa. Neuroinflammation, encompassing glial cell activation and cytokine secretion, is a major factor in the pathobiology of TBI and stroke. In Alzheimer's disease, neuroinflammation is both a reaction against and a contribution to the neurodegenerative pathology.All these articles emphasize the importance of the subject of neuroimmunology in Africa, in some cases because of the peculiarities the continent has in terms of infectious diseases but also for its importance to healthcare including diagnosis, treatment and understanding the neurological disorders that occur as sequalae of infectious diseases as well as noncommunicable neurological disorders. Various knowledge gaps are highlighted that necessitates further research in these various disorders. This research will not only benefit the African continent but the world at large in understanding the CNS, neuroimmunology and neuroinflammation. For example, trypan dyes developed by Paul Ehrlich in search of drugs to kill African trypanosomes aided Edwin E. Goldmann to discover the BBB [7].

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0